Allegro Diagnostics' Series A - II Round

Allegro Diagnostics raised a round of funding on July 07, 2011.

Allegro Diagnostics is a molecular diagnostics company focused on the development and commercialization of genomic tests to support the diagnosis and management of lung cancer. These tests have the po…

Articles about Allegro Diagnostics' Series A - II Round: